South San Francisco, CA May 10, 2017 Genentech Press Release 20 Genentech medicines are included in more than 190 abstracts during ASCO 2017 New pivotal results for Perjeta® (pertuzumab) and Alecensa® (alectinib) demonstrating improvement over standards of care Early…